AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15799734
Drug: Lidocaine 2%
RxNorm normalized name: LIDOCAINE 2% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 2% gel topically
Trial: 1897347
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine 4 ml.h‐1 (BUPI‐group)
Trial: 1897347
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg morphine bolus followed by 0.2 mg.h‐1 (MO‐group)
Trial: 1897347
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of bupivacaine and morphine (COMB-group)
Trial: 30239650
Drug: Cenicriviroc (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cenicriviroc (100 mg dose)
Trial: 27046162
Drug: Ticagrelor (pooled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor (pooled doses)
Trial: 23030511
Drug: Long-pulsed Nd:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-pulsed Nd:YAG laser (LPNY) treatment
Trial: 10404908
Drug: Zanamivir (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zanamivir (10 mg once daily for 4 weeks)
Trial: 7758492
Drug: Gentamicin 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 4.5 mg/kg once daily
Trial: 7758492
Drug: Gentamicin 1.5
RxNorm normalized name: HYDROCORTISONE ACEPONATE 1.11 mg in 1 mL / MICONAZOLE NITRATE 17.4 mg in 1 mL / GENTAMICIN 1.5 mg in 1 mL AURICULAR (OTIC) SUSPENSION [EASOTIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 1.5 mg/kg every eight hours (thrice daily)
Trial: 24119112
Drug: TY 8
RxNorm normalized name: Maxclarity 8 %
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TY 8 mg (bisoprolol transdermal patch)
Trial: 24119112
Drug: BO 5
RxNorm normalized name: placebo 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BO 5 mg (bisoprolol fumarate oral formulation)
Trial: 12359793
Drug: Dexamethasone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.5 mg/kg/d for 2 days, then 0.25 mg/kg/d for 2 days)
Trial: 9695133
Drug: Lupron injections
RxNorm normalized name: Lupron Injectable Product
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lupron injections (GnRH agonist) followed by resuming menstrual cycles (Cycle)
Trial: 2475059
Drug: four different
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: four different oral refeeding regimes
Trial: 23336668
Drug: Glimepiride/metformin (GM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride/metformin (GM) 1/250 mg twice daily
Trial: 23336668
Drug: Glimepiride/metformin sustained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride/metformin sustained release (GM-SR) 2/500 mg once daily
Trial: 15073257
Drug: (188)Re-HDD/lipiodol therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (188)Re-HDD/lipiodol therapy
Trial: 15073257
Drug: (131)I-lipiodol therapy
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (131)I-lipiodol therapy
Trial: 15078725
Drug: Dobutamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dobutamine (10 micro g/kg/min for 8 h every 14 days) + oral amiodarone (400 mg/d)
Trial: 15078725
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + oral amiodarone (400 mg/d)
Trial: 11427359
Drug: Uncoated placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uncoated placebo tablet (round)
Trial: 11427359
Drug: Film-coated placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Film-coated placebo risedronate tablet (oval)
Trial: 2700320
Drug: Ketanserin 20
RxNorm normalized name: ketanserin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin 20 mg twice daily for 15 days, then 40 mg twice daily for 45 days
Trial: 2700320
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg once daily for 60 days
Trial: 765382
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (100 mug 4 times daily)
Trial: 27721190
Drug: Behavioral activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral activation for depression via same-room treatment
Trial: 26125257
Drug: Infrared polarized
RxNorm normalized name: Polar Freeze
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infrared polarized light therapy (group B)
Trial: 26125257
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin treatment (group C)
Trial: 26125257
Drug: Joint treatment
RxNorm normalized name: ARNICA MONTANA FLOWER 2 g in 20 g / APIS MELLIFERA VENOM 6 g in 20 g TOPICAL CREAM [HOUKEA Venom Flex Joint Treatment Balm]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Joint treatment (group D)
Trial: 7948439
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not specified what treatment)
Trial: 7884789
Drug: Enalapril (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (12.5 +/- 6.5 mg/day)
Trial: 2905254
Drug: roxatidine acetate
RxNorm normalized name: roxatidine acetate
DrugBank: Roxatidine acetate (DB08806)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxatidine acetate 75 mg daily
Trial: 2905254
Drug: roxatidine acetate
RxNorm normalized name: roxatidine acetate
DrugBank: Roxatidine acetate (DB08806)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxatidine acetate 150 mg daily
Trial: 31472811
Drug: Evidence-based multifaceted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based multifaceted intervention including automated identification of patients at increased risk for CI-AKI, point-of-care information on safe contrast volume targets, personalized recommendations for hemodynamic optimization of intravenous fluids, and follow-up information for patients at risk.
Trial: 23449352
Drug: Sequential transarterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential transarterial chemoembolisation (sTACE) with cisplatin 50 mg administered intrarterially 4‐6 hours before PVA embolisation, repeated 3-weekly for up to three treatments
Trial: 23449352
Drug: Transarterial embolisation
RxNorm normalized name: Drugs for embolisation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transarterial embolisation (TAE) with polyvinyl alcohol (PVA) particles alone, repeated 3-weekly for up to three treatments
Trial: 19372355
Drug: Continuous ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ropivacaine perineural infusion (n = 15)
Trial: 19372355
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline infusion (n = 15)
Trial: 19372355
Drug: Continuous ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ropivacaine perineural infusion
Trial: 15131791
Drug: Epoetin alfa,
RxNorm normalized name: EPOETIN ALFA,RECOMBINANT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin alfa, 40,000 U subcutaneously, once weekly
Trial: 15374309
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (informal monthly meetings of the Alzheimer's Society)
Trial: 2646896
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose hydrochlorothiazide (HCTZ), 25 mg twice daily, with dose reduction
Trial: 2646896
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose hydrochlorothiazide (HCTZ), 50 mg twice daily, with dose reduction
Trial: 2646896
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose HCTZ plus a low or high dose of a step II drug (propranolol, clonidine or reserpine), with dose reduction
Trial: 2646896
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving continued treatment
Trial: 30545702
Drug: Standard post-operative
RxNorm normalized name: Sx1 Medicated Post-Operative System KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard post-operative analgesia (paracetamol and dexketoprofen)
Trial: 27435514
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (250 mg bolus followed by 500 mg infusion at 20 mL/hour)
Trial: 11880827
Drug: Piroxicam fast-dissolving
RxNorm normalized name: melatonin
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Piroxicam fast-dissolving dosage form (2 tablets sublingually 1 to 3 hours before surgery, repeated with 2 tablets after 24 hours, then 1 tablet after 48 hours)
Trial: 11880827
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 tablets administered sublingually 1 to 3 hours before surgery, repeated with 2 tablets after 24 hours, then 1 tablet after 48 hours)
Trial: 7589042
Drug: i.v. 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. 0.2 mg moxonidine
Trial: 23815518
Drug: Natural cholesterol‐lowering
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural cholesterol‐lowering supplement (NCLS)
Trial: 19626475
Drug: Gadobutrol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gadobutrol (0.1 ml/kg)
Trial: 17908831
Drug: Osteopathic manipulative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteopathic manipulative treatment (OMT) administered 1 hour before blood collection
Trial: 15520759
Drug: Probiotic lactobacilli
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic lactobacilli (Lactobacillus rhamnosus 19070‐2 and L reuteri DSM 12246) for 6 weeks
Trial: 15520759
Drug: Probiotic lactobacilli
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic lactobacilli (Lactobacillus rhamnosus 19070‐2 and L reuteri DSM 12246)
Trial: 7839785
Drug: Clonidine 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 3 micrograms.kg‐1 mixed with 15 mg 0.5% bupivacaine
Trial: 7839785
Drug: Saline mixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline mixed with 15 mg 0.5% bupivacaine
Trial: 24731441
Drug: mCBT (guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mCBT (guided Internet-based cognitive behavior therapy)
Trial: 24731441
Drug: mIPT (guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mIPT (guided self-help treatment based on interpersonal psychotherapy)
Trial: 10697029
Drug: Paclitaxel 200
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 200 mg/m2 plus carboplatin (AUC = 6)
Trial: 8222793
Drug: Cefpodoxime proxetil
RxNorm normalized name: Cefpodoxime Proxetil
DrugBank: Cefpodoxime (DB01416)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefpodoxime proxetil (200 mg, bid)
Trial: 8473547
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg once daily
Trial: 31609709
Drug: Antibiotic and
RxNorm normalized name: Triple Antibiotic And Pain Relief
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotic and antimycotic impregnated PICC (IP-PICC)
Trial: 16158748
Drug: Conventional postoperative
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional postoperative etiotropic therapy
Trial: 7735445
Drug: Amoxicillin-clavulanate
RxNorm normalized name: amoxicillin-clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanate
Trial: 15293527
Drug: Enalapril (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10-20 mg/day)
Trial: 2540054
Drug: Nicardipine (60-120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (60-120 mg/day)
Trial: 30192802
Drug: Cetuximab treatment
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab treatment during stimulation with IFNγ and TNFα
Trial: 30192802
Drug: Chemical inhibition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemical inhibition of EGFR signaling (using MEK1/2 inhibitor PD98059 and JNK inhibitor SP600125)
Trial: 30192802
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment with cetuximab and MEK1/2 or JNK inhibitor
Trial: 27342447
Drug: Ketamine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (100 ng/mL target plasma concentration)
Trial: 8030656
Drug: Placebo (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intravenous saline)
Trial: 20398482
Drug: Benidipine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benidipine (8 mg/d)
Trial: 9848776
Drug: Valsartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (80 mg/d)
Trial: 9764629
Drug: Oral HRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral HRT
Trial: 9764629
Drug: Transdermal HRT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal HRT
Trial: 9211571
Drug: Paroxetine 20
RxNorm normalized name: PARoxetine 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 20 mg daily
Trial: 3284322
Drug: Propranolol (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (60 or 80 mg 3 times daily)
Trial: 1095307
Drug: Bromhexine, 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromhexine, 16 mg, 3-times daily for 3 weeks
Trial: 25887128
Drug: Cuticerin™ (smooth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cuticerin™ (smooth acetate gauze with water-repellent ointment)
Trial: 19214143
Drug: Montelukast (cys-leukotriene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (cys-leukotriene receptor antagonist)
Trial: 21867401
Drug: Oral tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tranexamic acid (TA)
Trial: 16390353
Drug: Rifampicin 600
RxNorm normalized name: Rifampicin 600 mg powder for solution for infusion vial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin 600 mg once daily for 6 days
Trial: 30691748
Drug: Traditional Dysphagia
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional Dysphagia Therapy (TDT) - sensorimotor exercises and swallowing maneuvers
Trial: 30691748
Drug: Usual Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual Care (UC) - diet prescription and postural changes
Trial: 28834296
Drug: Postoperative antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative antibiotics (group B)
Trial: 16882893
Drug: Bupivacaine (alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (alone or in combination with betamethasone)
Trial: 7956538
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of low dosed or low molecular heparin into the contralateral abdominal wall
Trial: 7956538
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of low dosed or low molecular heparin into the thigh
Trial: 40816
Drug: Phenazepam (0.0025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenazepam (0.0025 mg/kg)
Trial: 40816
Drug: Diazepam (0.005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.005 mg/kg)
Trial: 20673485
Drug: Post-chemotherapy tumor
RxNorm normalized name: human breast tumor cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-chemotherapy tumor extent (GTV-T) irradiation
Trial: 20673485
Drug: Pre-chemotherapy tumor
RxNorm normalized name: human breast tumor cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-chemotherapy tumor extent (GTV-T) irradiation
Trial: 18397701
Drug: Cinacalcet (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet (30 - 180 mg/day)
Trial: 4014796
Drug: 5 units
RxNorm normalized name: Omnipod GO 15 Units/Day Pods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 units oxytocin in intravenous infusion throughout the procedure
Trial: 21436229
Drug: Mitoxantrone (MITOX)
DrugBank: Mitoxantrone (DB01204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitoxantrone (MITOX) monthly (12 mg/m²; maximum 20 mg) combined with 1 g of methylprednisolone (MP) for 6 months followed by interferon beta-1b (IFN) for the last 27 months
Trial: 21436229
Drug: Interferon beta-1b
RxNorm normalized name: Interferon Beta-1B
DrugBank: Interferon beta-1b (DB00068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta-1b (IFN) for 3 years combined with 1 g of methylprednisolone (MP) monthly for the first 6 months
Trial: 17511904
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment using modified Luque III instrumentation
Trial: 15356403
Drug: Levormeloxifene (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levormeloxifene (5 mg/kg/day)
Trial: 15356403
Drug: Levormeloxifene (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levormeloxifene (0.2 mg/kg/day)
Trial: 2033963
Drug: CNS prophylaxis
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CNS prophylaxis with intermediate dose methotrexate (MTX) and intrathecal MTX
Trial: 6803279
Drug: Imipramine (50‐200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (50‐200 mg/day)
Trial: 6803279
Drug: Nortriptyline with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nortriptyline with perphenazine (8‐16 mg/day)
Trial: 14731120
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon (IFN)-alpha 2b (10 MU/m2) thrice/weekly for 6 months
Trial: 8311217
Drug: 2% lignocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% lignocaine gel applied to Filshie clips
Trial: 8311217
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no lignocaine gel)
Trial: 6779334
Drug: diazepam 2
RxNorm normalized name: diazepam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam 2 mg
Trial: 6134543
Drug: diazepam 5
RxNorm normalized name: diazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam 5 mg
Trial: 31334703
Drug: rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 10 mg/day and EPA 1,800 mg/day
Trial: 31334703
Drug: rosuvastatin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 2.5 mg/day
Trial: 21857944
Drug: Olanzapine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (10 mg/day) for three days prior to oGTT testing
Trial: 31075442
Drug: Moxifloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin (400 mg oral)
Trial: 14756383
Drug: Itraconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (200 mg oral)
Trial: 11466256
Drug: All three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All three drugs (Timolol, Betaxolol, Carteolol)
Trial: 3360173
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg norethisterone (NE)
Trial: 26330412
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Ezetimibe/simvastatin and Simvastatin)
Trial: 21205113
Drug: IV fructose
RxNorm normalized name: Fructose
DrugBank: Fructose (DB04173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV fructose (0.3 mg/kg)
Trial: 8824693
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg spirapril (chronic treatment)
Trial: 8824693
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg spirapril (first dose)
Trial: 8824693
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg spirapril
Trial: 8824693
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg spirapril
Trial: 3918993
Drug: Imipramine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (50 mg/day, increased to 100-300 mg/day)
Trial: 17065257
Drug: Bivalent meningococcal
RxNorm normalized name: MENINGOCOCCAL B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent meningococcal outer membrane vesicle vaccine (B:4:P1.19,15 and B:4:P1.7‐2,4)
Trial: 17065257
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (two doses of hepatitis A and one of conjugated meningococcal serogroup C vaccine on a 0-1-6 month schedule)
Trial: 16263208
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement (soy, isoflavones, lycopene, silymarin, antioxidants)
Trial: 10450255
Drug: Clozapine add-on
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine add-on treatment
Trial: 395525
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg danazol daily for 100 days